Connect With a Community of Oligonucleotide Therapeutics Experts
Why Partner with the Oligonucleotide Therapeutics Summit
Oligonucleotide therapeutics stand at an inflection point. As ASOs, siRNAs and next-generation modalities push beyond rare disease into neurology, oncology and cardiometabolic indications, drug developers face mounting pressure to solve extrahepatic delivery, conjugate design, manufacturability, and CMC scale-up, often without the internal expertise or capacity to do it alone.
That is where you come in.
The Oligonucleotide Therapeutics Summit brings together the biopharma and biotech teams actively wrestling with these bottlenecks, creating a focused, high-value environment for solution providers, CDMOs, CROs and technology partners to engage directly with the people making build-versus-buy and outsourcing decisions. This isn't a broad RNA therapeutics trade show, it's a technical, innovation-focused meeting where the conversations that matter happen.
As a partner, you will position your capabilities in front of senior decision-makers urgently seeking partners who can solve challenges around capacity, timelines, bioavailability and quality, while building the credibility and visibility that turns conversations into pipeline. With Novartis's $12 billion acquisition of Avidity Biosciences and its muscle-targeted Antibody Oligonucleotide Conjugate platform, and AstraZeneca's siRNA collaboration with CSPC Pharmaceutical built around an extrahepatic-targeted delivery platform, extrahepatic delivery is now driving a wave of licensing and dealmaking activity across the industry, and there's never been a better moment to establish your presence at the table.
What to Expect?
Meet New Clients
Expand your client base by networking face-to-face with dedicated attendees actively seeking solutions across extrahepatic & CNS delivery, conjugation chemistry, and CMC & manufacturing scale-up
Demonstrate Your Expertise
Present your work within one of our focused sessions, participate in a panel discussion, or contribute to our workshop day to demonstrate your company's unique capabilities in oligonucleotide chemistry and delivery
Centre Yourself in Oligonucleotide Dealmaking
Position your brand in front of the scientists and Director-level decision-makers shaping oligonucleotide development by showcasing your company logo on event materials including our website, brochure, and on-site signage
Gain Market Intelligence
Stay ahead of industry trends by hearing directly from the scientists and pharma BD leaders shaping the field. Gain insights into competitor strategies and emerging chemistries to sharpen your organization's competitive edge
Key Sponsor Areas/Capabilities
Our attendees from leading biopharma and biotech companies are looking for service and solution providers with capabilities in the below areas but not limited to:
- Preclinical CROs supporting toxicology studies, oligo delivery assessment, pharmacology and safety profiling in rodent and other preclinical models
- Clinical CROs, facilitating clinical testing of oligonucleotides in human trials
- Oligo Synthesis, from micro-scale, non-GMP synthesis for early discovery through to custom oligos with complex chemical or sequence modifications
- Oligo Manufacturing (CMOs), GMP-grade manufacturing and scale-up for later preclinical and clinical studies
- Oligo Analytics & Characterization, impurity, safety and stability testing to support regulatory submission packages
- Drug Delivery, platforms and technologies enabling systemic, local or direct-to-tissue administration of oligonucleotides
Hear What Our Past Sponsors Have to Say
The meeting was very interactive. The balance between the presentation and the roundtable discussion was really good. I learned a lot and made valuable connections as well.
Fujifilm
It was great to hear where the field is at and what the challenges are. Good to get different perspectives and point of views of how to tackle them.
Grunenthal
Attending Companies Include
Available Inventory
We have a range of inventory from standard booths and speaking slots to more bespoke deliverables such as branding, exclusive dinners, and hosted networking, all designed to help elevate your brand at the Oligonucleotide Therapeutics Summit.
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us at sponsor@hansonwade.com if you would like to get involved and discuss a bespoke package suited to your needs.
Tazeen Kapadia
Partnerships Director